Thomas H. Fraser
Plus aucun poste en cours
Historique de carrière de Thomas H. Fraser
Anciens postes connus de Thomas H. Fraser
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GENVEC INC | Directeur/Membre du Conseil | - | 01/01/2006 |
| President | - | 01/01/2006 | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | - | - |
| President | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 2 |
| President | 2 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Health Technology |
- Bourse
- Insiders
- Thomas H. Fraser
- Expérience
